140 related articles for article (PubMed ID: 38146639)
1. New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease.
Samanta S; Akhter F; Roy A; Chen D; Turner B; Wang Y; Clemente N; Wang C; Swerdlow RH; Battaile KP; Lovell S; Yan SF; Yan SS
Brain; 2024 May; 147(5):1710-1725. PubMed ID: 38146639
[TBL] [Abstract][Full Text] [Related]
2. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease.
Du H; Guo L; Fang F; Chen D; Sosunov AA; McKhann GM; Yan Y; Wang C; Zhang H; Molkentin JD; Gunn-Moore FJ; Vonsattel JP; Arancio O; Chen JX; Yan SD
Nat Med; 2008 Oct; 14(10):1097-105. PubMed ID: 18806802
[TBL] [Abstract][Full Text] [Related]
3. Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury.
Panel M; Ruiz I; Brillet R; Lafdil F; Teixeira-Clerc F; Nguyen CT; Calderaro J; Gelin M; Allemand F; Guichou JF; Ghaleh B; Ahmed-Belkacem A; Morin D; Pawlotsky JM
Gastroenterology; 2019 Nov; 157(5):1368-1382. PubMed ID: 31336123
[TBL] [Abstract][Full Text] [Related]
4. Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model.
Du H; Guo L; Zhang W; Rydzewska M; Yan S
Neurobiol Aging; 2011 Mar; 32(3):398-406. PubMed ID: 19362755
[TBL] [Abstract][Full Text] [Related]
5. Structure based design, synthesis, pharmacophore modeling, virtual screening, and molecular docking studies for identification of novel cyclophilin D inhibitors.
Valasani KR; Vangavaragu JR; Day VW; Yan SS
J Chem Inf Model; 2014 Mar; 54(3):902-12. PubMed ID: 24555519
[TBL] [Abstract][Full Text] [Related]
6. Discovery of non-peptidic small molecule inhibitors of cyclophilin D as neuroprotective agents in Aβ-induced mitochondrial dysfunction.
Park I; Londhe AM; Lim JW; Park BG; Jung SY; Lee JY; Lim SM; No KT; Lee J; Pae AN
J Comput Aided Mol Des; 2017 Oct; 31(10):929-941. PubMed ID: 28913661
[TBL] [Abstract][Full Text] [Related]
7. Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration.
Du H; Guo L; Wu X; Sosunov AA; McKhann GM; Chen JX; Yan SS
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2517-27. PubMed ID: 23507145
[TBL] [Abstract][Full Text] [Related]
8. Genetic Approach to Elucidate the Role of Cyclophilin D in Traumatic Brain Injury Pathology.
Readnower RD; Hubbard WB; Kalimon OJ; Geddes JW; Sullivan PG
Cells; 2021 Jan; 10(2):. PubMed ID: 33498273
[TBL] [Abstract][Full Text] [Related]
9. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons.
Guo L; Du H; Yan S; Wu X; McKhann GM; Chen JX; Yan SS
PLoS One; 2013; 8(1):e54914. PubMed ID: 23382999
[TBL] [Abstract][Full Text] [Related]
10. Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/ release.
Guo HX; Wang F; Yu KQ; Chen J; Bai DL; Chen KX; Shen X; Jiang HL
Acta Pharmacol Sin; 2005 Oct; 26(10):1201-11. PubMed ID: 16174436
[TBL] [Abstract][Full Text] [Related]
11. F1F0 ATP Synthase-Cyclophilin D Interaction Contributes to Diabetes-Induced Synaptic Dysfunction and Cognitive Decline.
Yan S; Du F; Wu L; Zhang Z; Zhong C; Yu Q; Wang Y; Lue LF; Walker DG; Douglas JT; Yan SS
Diabetes; 2016 Nov; 65(11):3482-3494. PubMed ID: 27554467
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.
Rao VK; Carlson EA; Yan SS
Biochim Biophys Acta; 2014 Aug; 1842(8):1267-72. PubMed ID: 24055979
[TBL] [Abstract][Full Text] [Related]
13. Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore.
Nguyen TT; Stevens MV; Kohr M; Steenbergen C; Sack MN; Murphy E
J Biol Chem; 2011 Nov; 286(46):40184-92. PubMed ID: 21930693
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.
Du H; Yan SS
Biochim Biophys Acta; 2010 Jan; 1802(1):198-204. PubMed ID: 19616093
[TBL] [Abstract][Full Text] [Related]
15. Cyclophilin D deficiency attenuates mitochondrial F1Fo ATP synthase dysfunction via OSCP in Alzheimer's disease.
Gauba E; Chen H; Guo L; Du H
Neurobiol Dis; 2019 Jan; 121():138-147. PubMed ID: 30266287
[TBL] [Abstract][Full Text] [Related]
16. Cyclophilin D-mediated Mitochondrial Permeability Transition Regulates Mitochondrial Function.
Zhou S; Yu Q; Zhang L; Jiang Z
Curr Pharm Des; 2023; 29(8):620-629. PubMed ID: 36915987
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Small Molecule Cyclophilin D Inhibitor for Rescuing Aβ-Mediated Mitochondrial Dysfunction.
Valasani KR; Sun Q; Fang D; Zhang Z; Yu Q; Guo Y; Li J; Roy A; ShiDu Yan S
ACS Med Chem Lett; 2016 Mar; 7(3):294-9. PubMed ID: 26985318
[TBL] [Abstract][Full Text] [Related]
18. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
Xie Y; Tan Y; Zheng Y; Du X; Liu Q
J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
[TBL] [Abstract][Full Text] [Related]
19. A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.
Panel M; Ahmed-Belkacem A; Ruiz I; Guichou JF; Pawlotsky JM; Ghaleh B; Morin D
J Pharmacol Exp Ther; 2021 Mar; 376(3):348-357. PubMed ID: 33303698
[TBL] [Abstract][Full Text] [Related]
20. Cysteine 202 of cyclophilin D is a site of multiple post-translational modifications and plays a role in cardioprotection.
Amanakis G; Sun J; Fergusson MM; McGinty S; Liu C; Molkentin JD; Murphy E
Cardiovasc Res; 2021 Jan; 117(1):212-223. PubMed ID: 32129829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
